(0671–0694) Antiphospholipid Syndrome Poster

Sunday, November 13, 2022

9:00 AM – 10:30 AM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

9:00 AM – 10:30 AM Eastern Time

Thrombocytopenia and Autoimmune Hemolytic Anemia in Antiphospholipid Antibody-positive Patients: Descriptive Analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
Abstract Poster Presenter: Zeynep Belce Erton, MD – Hospital for Special Surgery- SUNY Downstate Medical Center
9:00 AM – 10:30 AM Eastern Time

Immune Thrombocytopenia Could Be an Independent Phenotype of Primary Antiphospholipid Syndrome
Abstract Poster Presenter: Yu Shi, MD – Chinese Academy of Medical Sciences, Peking Union Medical College
9:00 AM – 10:30 AM Eastern Time

Occurrence and Severity of Bleeding in Adults with Immunogenic Thrombocytopenic Purpura with or Without Antiphospholipid Autoantibodies
Abstract Poster Presenter: Izabella Elgardt, MD – Meir Hospital
9:00 AM – 10:30 AM Eastern Time

Prevalence of Heparin Induced Thrombocytopenia in Hospitalized Patients with Antiphospholipid Syndrome or Systemic Lupus Erythematosus with Antiphospholipid Antibodies
Abstract Poster Presenter: Vincent Tran, MD – UCLA
9:00 AM – 10:30 AM Eastern Time

Clinical Characteristics and Factors Associated with Relapse and Mortality in Diffuse Alveolar Hemorrhage Among Patients with Antiphospholipid Syndrome: A Multi-Center Retrospective Cohort
Abstract Poster Presenter: Jose Meade-Aguilar, MD – Mayo Clinic
9:00 AM – 10:30 AM Eastern Time

Presentation and Outcomes in Patients with Adrenal Hemorrhage Associated with Antiphospholipid Syndrome: A Cohort Study and Systematic Review of Literature
Abstract Poster Presenter: Jose Meade-Aguilar, MD – Mayo Clinic
9:00 AM – 10:30 AM Eastern Time

Obstructive Sleep Apnea in Primary Antiphospholipid Syndrome Impacts Damage Accrual
Abstract Poster Presenter: Gustavo Balbi, MD – Universidade de Sao Paulo
9:00 AM – 10:30 AM Eastern Time

Inpatient Epidemiology, Expenditures and Resource Utilization of Antiphospholipid Syndrome: National Inpatient Sample 2019
Abstract Poster Presenter: Patompong Ungprasert, MD, MS – Cleveland Clinic, Cleveland, OH
9:00 AM – 10:30 AM Eastern Time

Outcomes of Antiphospholipid Antibody Syndrome and Acute Coronary Syndrome: Analysis of National Inpatient Sample 
Abstract Poster Presenter: Faria Sami, MD, MBBS – John H. Stroger Hospital of Cook County
9:00 AM – 10:30 AM Eastern Time

Association of Environmental Risk Factors with Antiphospholipid Antibodies and Thrombosis in 1199 International Patients Referred for Suspected Antiphospholipid Syndrome
Abstract Poster Presenter: Medha Barbhaiya, MD, MPH – Hospital for Special Surgery
9:00 AM – 10:30 AM Eastern Time

Antiphospholipid Antibodies and Incident Cardiovascular Events in a Diverse Population: Results from the Dallas Heart Study
Abstract Poster Presenter: Yu (Ray) Zuo, MD, MS – University of Michigan
9:00 AM – 10:30 AM Eastern Time

Analysis of Recurrent Thrombotic Events in a Large Single-center Primary Antiphospholipid Syndrome Cohort: Results from APS-Rio Cohort After over Than 600 Patients-year of Follow-up
Abstract Poster Presenter: Gustavo Balbi, MD – Universidade de Sao Paulo
9:00 AM – 10:30 AM Eastern Time

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients Without Other Systemic Autoimmune Diseases: Clinical and Serological Characteristics, Results from the APS ACTION Clinical Database and Repository
Abstract Poster Presenter: Savino Sciascia, MD – University of Turin
9:00 AM – 10:30 AM Eastern Time

Single Antiphospholipid Antibody Positive Thrombotic APS Patients’ Clinical Characteristics: Retrospective Results from the APS ACTION Clinical Database and Repository (Registry)
Abstract Poster Presenter: Savino Sciascia, MD – University of Turin
9:00 AM – 10:30 AM Eastern Time

The Association of Antiphospholipid Antibodies with Previous SARS-CoV-2 Infection Among Elective Knee Replacement Patients
Abstract Poster Presenter: Lisa Mandl, MD, MPH – Hospital for Special Surgery
9:00 AM – 10:30 AM Eastern Time

Anti-β2GP1/HLA-DR Antibody Is Associated with Arterial Thrombosis in Female Patients with Connective Tissue Diseases: A Cross-Sectional Study in Japan
Abstract Poster Presenter: Katsuhiko Yoneda, MD – Kobe University Graduate School of Medicine
9:00 AM – 10:30 AM Eastern Time

DNA- and NET-Binding Beta-2 Glycoprotein I in a Large Cohort of Antiphospholipid Antibody-Positive Patients
Abstract Poster Presenter: Katarina Kmetova, BSc, MSc – Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA
9:00 AM – 10:30 AM Eastern Time

Antibodies of the IgA Isotype Target Neutrophil Extracellular Traps in APS
Abstract Poster Presenter: Sherwin Navaz, BS – University of Michigan
9:00 AM – 10:30 AM Eastern Time

Type I Interferon Stimulated Genes Identify Different Phenotypes of Antiphospholipid Syndrome Patients
Abstract Poster Presenter: Savino Sciascia, MD – University of Turin
9:00 AM – 10:30 AM Eastern Time

The Physiological Ketone Body Beta-Hydroxybutyrate Potently Neutralizes APS-Associated NETosis
Abstract Poster Presenter: Ajay Tambralli, MD – University of Michigan
9:00 AM – 10:30 AM Eastern Time

WITHDRAWN
9:00 AM – 10:30 AM Eastern Time

The Interplay Between Lipid Peroxidation and Neutrophil Extracellular Trap (NET) Formation in APS Pathogenesis
Abstract Poster Presenter: NaveenKumar Somanathapura, PhD – University of Mysore, Karnataka, India
9:00 AM – 10:30 AM Eastern Time

Low Neutrophil Ectonucleotidase Activity Drives Neutrophil-Platelet Aggregation and Platelet Activation in Antiphospholipid Syndrome (APS)
Abstract Poster Presenter: NaveenKumar Somanathapura, PhD – University of Mysore, Karnataka, India
9:00 AM – 10:30 AM Eastern Time

Evaluation of the Effect of UCB4470 (anti-mouse FcRn) on Amelioration of Thrombosis in a Mouse Model of Antiphospholipid (aPL)-induced Thrombosis
Abstract Poster Presenter: Maria Laura Bertolaccini, PhD – King's College London